Prozac Weekly

   
Google
 
Web NewDrugInformation.com

Prozac Weekly


Drug - Prozac Weekly
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, DELAYED REL PELLETS; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Fluoxetine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 90MG BASE
The potency of the active ingredient(s), Fluoxetine Hydrochloride. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Prozac Weekly. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021235
The FDA assigned number to Prozac Weekly. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Prozac Weekly. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 26, 2001
The date Prozac Weekly was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Prozac Weekly. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Prozac Weekly is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Prozac Weekly.

Prozac Weekly